Rhythm Pharmaceuticals (RYTM) Research & Development (2020 - 2025)
Historic Research & Development for Rhythm Pharmaceuticals (RYTM) over the last 6 years, with Q3 2025 value amounting to $46.0 million.
- Rhythm Pharmaceuticals' Research & Development rose 2134.4% to $46.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $166.5 million, marking a year-over-year decrease of 2655.97%. This contributed to the annual value of $238.0 million for FY2024, which is 7632.84% up from last year.
- Latest data reveals that Rhythm Pharmaceuticals reported Research & Development of $46.0 million as of Q3 2025, which was up 2134.4% from $42.3 million recorded in Q2 2025.
- Rhythm Pharmaceuticals' Research & Development's 5-year high stood at $128.7 million during Q1 2024, with a 5-year trough of $19.9 million in Q1 2021.
- Moreover, its 5-year median value for Research & Development was $32.5 million (2022), whereas its average is $37.4 million.
- Per our database at Business Quant, Rhythm Pharmaceuticals' Research & Development soared by 23908.29% in 2024 and then crashed by 7126.41% in 2025.
- Quarter analysis of 5 years shows Rhythm Pharmaceuticals' Research & Development stood at $31.6 million in 2021, then fell by 25.42% to $23.5 million in 2022, then grew by 26.94% to $29.9 million in 2023, then surged by 37.72% to $41.2 million in 2024, then increased by 11.8% to $46.0 million in 2025.
- Its Research & Development was $46.0 million in Q3 2025, compared to $42.3 million in Q2 2025 and $37.0 million in Q1 2025.